| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 22,295,933 | 22,939,660 | 17,226,825 | | Cost of Revenue | 11,917,601 | 11,872,840 | 8,289,600 | | | Gross Profit | 10,378,333 | 11,066,820 | 8,937,225 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 5,048,458 | 3,170,214 | 2,296,125 | | Non Recurring |
-
|
-
|
-
| | Others | 1,601,805 | 1,983,129 | 1,709,338 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,728,070 | 5,913,476 | 4,931,763 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,869,010 | 2,511,831 | 1,212,825 | | Earnings Before Interest And Taxes | 5,604,186 | 8,433,288 | 6,144,588 | | Interest Expense | 3,622,894 | 4,060,029 | 3,744,450 | | Income Before Tax | 1,981,292 | 4,373,259 | 2,400,138 | | Income Tax Expense | 670,854 | 1,219,006 | 257,088 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,310,439 | 3,154,253 | 2,143,050 | | | Non-recurring Events | | Discontinued Operations | 35,533 | 3,228,072 | 105,975 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,345,971 | 6,382,325 | 2,249,025 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,345,971 | $6,382,325 | $2,249,025 |
|
0.29% Nasdaq 
Income Statement
